The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.
The Wall Street Journal on MSN22d
Purdue Pharma’s Sacklers Strike New $6.5 Billion Settlement of Opioid ClaimsPurdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday. The ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
Purdue Pharma is preparing to ... with the opioid crisis to go to trial, with J&J the remaining defendant after Purdue and Teva both settled out of court.
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
Hosted on MSN22d
Purdue Pharma owners strike new $6.5 billion deal in opioid caseThe billionaire family that owns Purdue Pharma, maker of the pain medication ... The deal comes after the Supreme Court in June blocked a controversial bankruptcy plan for Purdue that shielded ...
Purdue Pharma and its Sackler family owners have reached ... The settlement was announced nearly seven months after the U.S. Supreme Court upended the company’s previous attempt to resolve ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... that was rejected last year by the U.S. Supreme Court. The Sacklers agreed to pay up to $6.5 billion ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... that was rejected last year by the U.S. Supreme Court. In the new one, the Sacklers agreed to pay up ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results